Medscape
Long-approved drugs with decades of safety data are facing new scrutiny amid a charged political environment. The Trump administration’s new “Make America Healthy Again (MAHA) Commission” will investigate what it calls “the threat posed” to children by psychiatric and attention-deficit/hyperactivity disorder (ADHD) medications, as well as weight loss drugs. …
Read More
Trump Probes Long-Approved Meds; Could FDA Revoke Approvals?
Camellia Kazmierczak
07:20
Long-approved drugs with decades of safety data are facing new scrutiny amid a charged political environment. The Trump administration’s new “Make America Healthy Again (MAHA) Commission” will investigate what it calls “the threat posed” to children by psychiatric and attention-deficit/hyperactivity disorder (ADHD) medications, as well as weight loss drugs. …
